A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

May 4, 2022

Study Completion Date

May 4, 2022

Conditions
Fatty Acid Oxidation Disorder
Trial Locations (15)

2100

Rigshospitalet, Klinik for nerve- og muskelsygdomme, Copenhagen

3000

UZ Leuven University Hospitals Leuven, Leuven

12808

Vseobecna fakultni nemocnice v Praze, Klinika pediatrie a dedicnych poruch metabolizmu, Prague

15261

University of Pittsburgh, Pittsburgh

15706

Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Complejo Hospitalario Universitario de Santiago Travesía de Choupana s/n, Santiago de Compostela

25123

Universita di Brescia, Brescia

28041

Hospital 12 de Octubre, Madrid

37232

Vanderbuilt University Medical Center, Nashville

75013

Hôpital Pitié-Salpêtrière, Paris

97239

Oregon Health & Science University (OHSU), Portland

98124

"Azienda Ospedaliera Universitaria Policlinico G. Martino di Messina", Messina

A-6020

Medizinische Universität Innsbruck, Innsbruck

H-2143

Pest Megyei Flór Ferenc Kórház, Kistarcsa

80-952

Uniwersyteckie Centrum Kliniczne, Gdansk

M6 8HD

Salford Royal NHS Trust, Salford

All Listed Sponsors
lead

Reneo Pharma Ltd

INDUSTRY

NCT04482049 - A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders | Biotech Hunter | Biotech Hunter